These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Relation between myocardial perfusion, myocardial necrosis and residual glucose metabolism as a vitality parameter in the post-ischemic myocardium following coronary reperfusion]. Sochor H Acta Med Austriaca Suppl; 1989; 39():1-36. PubMed ID: 2787948 [TBL] [Abstract][Full Text] [Related]
4. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs. Abe Y; Kitada Y; Narimatsu A J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827 [TBL] [Abstract][Full Text] [Related]
5. Measurement of regional glucose metabolic rates in reperfused myocardium. Buxton DB; Schelbert HR Am J Physiol; 1991 Dec; 261(6 Pt 2):H2058-68. PubMed ID: 1750552 [TBL] [Abstract][Full Text] [Related]
6. Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965 [TBL] [Abstract][Full Text] [Related]
7. [Coronary vascular reaction in non-ischemic myocardium during experimental acute ischemia reperfusion]. Moĭbenko OO; Iuz'kiv MIa; Azarov VI Fiziol Zh (1994); 2003; 49(4):14-23. PubMed ID: 14509923 [TBL] [Abstract][Full Text] [Related]
8. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401 [TBL] [Abstract][Full Text] [Related]
9. Consequences of reperfusion following acute coronary occlusion. Meerbaum S; Lang TW; Corday E; Hirose S; Costantini C; Gold H Recent Adv Stud Cardiac Struct Metab; 1975; 10():423-33. PubMed ID: 1208993 [TBL] [Abstract][Full Text] [Related]
10. Newer concepts in the pathophysiology of ischemic heart disease. Kirk ES; Factor S; Sonnenblick EH G Ital Cardiol; 1984 Nov; 14(11):881-91. PubMed ID: 6526205 [TBL] [Abstract][Full Text] [Related]
11. Myocardial blood flow and metabolism in humans. Schelbert HR Z Kardiol; 1984; 73 Suppl 2():113-8. PubMed ID: 6335622 [TBL] [Abstract][Full Text] [Related]
12. Nicotinic acid, free fatty acids and myocardial function during coronary occlusion and reperfusion in the dog. Lamping KA; Menahan LA; Gross GJ J Pharmacol Exp Ther; 1984 Dec; 231(3):532-8. PubMed ID: 6502512 [TBL] [Abstract][Full Text] [Related]
13. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653 [TBL] [Abstract][Full Text] [Related]
14. Improvement of the metabolic and energetic situation of ischemically stressed myocardium by verapamil after experimental coronary artery occlusion. Korb H; Hoeft A; Baller D; Schräder R; Wolpers HG; Hellige G Arzneimittelforschung; 1983; 33(11):1546-51. PubMed ID: 6686450 [TBL] [Abstract][Full Text] [Related]
15. Non-elastic deformation of myocardium in low-flow ischemia and reperfusion: ultrastructure-function relations. Lu L; Xu Y; Greyson CR; Ursell PC; Schwartz GG J Mol Cell Cardiol; 1999 May; 31(5):1157-69. PubMed ID: 10336853 [TBL] [Abstract][Full Text] [Related]
16. Myocardial glycerol release, arrhythmias and hemodynamic instability during regional ischemia-reperfusion in an open chest pig model. Metzsch C; Liao Q; Steen S; Algotsson L Acta Anaesthesiol Scand; 2006 Jan; 50(1):99-107. PubMed ID: 16451157 [TBL] [Abstract][Full Text] [Related]
17. Regional function, blood flow, and oxygen utilization relations in repetitively occluded-reperfused canine myocardium. Vinten-Johansen J; Gayheart PA; Johnston WE; Julian JS; Cordell AR Am J Physiol; 1991 Aug; 261(2 Pt 2):H538-47. PubMed ID: 1877679 [TBL] [Abstract][Full Text] [Related]
18. Hyperlipidemia with hypoglycemia reduces myocardial oxygen utilization efficiency but not contractile function during coronary hypoperfusion. Hart BJ; Bian X; Mallet RT; Downey HF J Mol Cell Cardiol; 2000 Aug; 32(8):1539-52. PubMed ID: 10900179 [TBL] [Abstract][Full Text] [Related]